Status:
SUSPENDED
Antipsychotics and Metabolic Syndrome
Lead Sponsor:
Glostrup University Hospital, Copenhagen
Conditions:
Metabolic Syndrome
Eligibility:
MALE
18-45 years
Brief Summary
The purpose of the study is to determine whether antipsychotic treatment is influence psychiatric patients due to endocrine and metabolic status and quality of life.
Eligibility Criteria
Inclusion
- Gender male
- Age 18-45
- Debut drug-naive schizophrenics,
- Caucasians
- Consent given to take part in the project
Exclusion
- Compliance-problems
- Major lung-/kidney/hart/lever disorders
- Abuse of alcohol/drugs
- Diabetes 1 and 2
- Antihypertensive
- Anticholesterol-reducing medication
- Patients under duress
Key Trial Info
Start Date :
September 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00636753
Start Date
September 1 2008
Last Update
July 30 2010
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Psychiatric Center Glostrup
Copenhagen, Nordre Ringvej 28-69, Glostrup, Denmark, 2600
2
Psychiatric Center Glostrup
Nordre Ringvej 28-69, Glostrup, Denmark, 2600